Multiple sclerosis: Prevalence and factors impacting bladder and bowel function in an Australian community cohort

Disability and Rehabilitation

Volumn 31, Issue 19, 2009, Pages 1567-1576

  Khan, Fary ^a   Pallant, Julie F ^b   Shea, Tracey L ^c   Whishaw, Michael ^d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Continence; Disability; Multiple sclerosis; Participation; Rehabilitation

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BLADDER FUNCTION; CONTROLLED STUDY; EMOTIONAL STABILITY; FECES INCONTINENCE; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; URINARY FREQUENCY; URINE INCONTINENCE;

ADULT; AGED; AUSTRALIA; COHORT STUDIES; FECAL INCONTINENCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; QUALITY OF LIFE; URINARY INCONTINENCE;

EID: 70849137133     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.1080/09638280802639566     Document Type: Article

References (42)

1. World Health Organization. Atlas: country resources for neurological disorders. Geneva: World Health Organization, 2004. Available from: http://www.who.int/mental-health/ neurology/neurology-atlas-review-references. pdf. Last accessed 26/2/2008.
2. Khan F, McPhail T, Brand C, Turner-Stokes L, Trevor K. Disability profile and quality of life in multiple sclerosis in an Australian community cohort. IJRR 2006;29:87-96.
3. Bonniaud V, Parratte B, Amarenco G, Jackowski D, Didier JP, Guyatt G. Measuring quality of life in multiple sclerosis patients with urinary disorders using the Qualiveen questionnaire. Arch Phys Med Rehabil 2004;85:1317-1323.
4. Crayton H, Heyman RA, Rossman HS. Multimodal approach to managing the symptoms of multiple sclerosis. Neurology 2004;63 (suppl5):S12-S18.
5. DasGupta R, Fowler CJ. Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs 2003; 63:153-166.
6. Hadjimichael O. NARCOMS Report. Bladder symptoms among registry participants. Mult Scler Q Rep 2002;21: 16-19.
7. Norvedt MW, Riise T, Myhr KM, Bakke A, Landblom AM, Nyland HI. Reduced quality of life among MS patients with sexual disturbance and bladder dysfunction. Mult Scler 2001;7:231-235.
8. Green JP, Smoker I, Ho MT, Moore KH. Urinary incontinence in subacute care: a retrospective analysis of clinical outcomes and costs. Med J Aust 2003;178:550-553.
9. World Health Organization (WHO). International classification of functioning, disability and health (ICF). Geneva: WHO, 2001.
10. Khan F, Pallant J. Use of the international classification of functioning, disability and health (ICF) to identify preliminary comprehensive and brief core sets for multiple sclerosis. Dis Rehabil 2007;29:205-213.
11. Khan F, Pallant J. Use of international classification of functioning and health (ICF) to describe patient reported disability in multiple sclerosis and identification of relevant environmental factors. J Rehabil Med 2007;39:63-70.
12. de Seze M, Ruffion A, Denys P, Pierre-Alain J, Perrouin-Verbe B. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 2007;13:915-928.
13. Mayo ME, Chetner MP. Lower urinary tract dysfunction in multiple sclerosis. Urology 1992;39:67-70.
14. Borello-France D, Leng W, O'Leary M, Xavier M, Erickson J, Chancellor MB, Cannon TW. Bladder and sexual function among women with multiple sclerosis. Mult Scler 2004;10: 455-461.
15. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
16. Bakke A, Myhr KM, Gronning M, Nyland H. Bladder, bowel and sexual dysfunction in patients with multiple sclerosis - a cohort study. Scand J Urol Nephrol Suppl 1996;176:61-66.
17. Hinds JP, Eidelman BH, Wald A. Prevalence of bowel dysfunction in multiple sclerosis. A population survey. Gastroenterology 1990;98:1538-1542.
18. Lam TCF, Kennedy ML, Chen FC, Lubowski DZ, Talley NJ. Prevalence of faecal incontinence: obstetric and constipation related risk factors: a population based study. Dis Colon Rectum 1999;1:197-203.
19. Norton C. Faecal incontinence in adults: prevalence and causes. Br J Nurs 1996;5:1366-1374.
20. Kamm MA. Faecal incontinence. BMJ 1998;316:528-532.
21. Weber J, Grise P, Roquebert M, Hellot MF, Mihout B, Samson M. Radio opaque markers transit and anorectal manometry in 16 patients with multiple sclerosis and urinary bladder dysfunction. Dis Colon Rectum 1987;30:95-100.
22. National Centre for clinical excellence: www.doh.gov.uk/ pricare/drugsmultiple sclerosis.htm, Last accessed 10 September 2006.
23. Continence outcomes measurement suite project final report. Victoria: Australian Government Department of Health and Aging and LaTrobe University, 2004.p 1-254. ISBN: 0642824088, Publication approval number: 3398/JN8293.
24. Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: report from the Standardization Sub committee of the International Continence Society. Am J Obstet Gynaecol 2002;187:116-126.
25. Royal College of Physicians. Incontinence. Causes, management and provision of services. A working party of the Royal College of Physicians. J R Coll Physicians Lond 1995;29:272-274.
26. Sharrack B, Hughes RAC. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler 1999;5:223-233.
27. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association Symptom Index for benign prostatic hyperplasia. The measurement committee of the American Urological Association. J Urol 1992;148:1549-1557.
28. Shumaker S, Wyman J, Uebersax J, McClish D, Fantl J. Health related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 1994;3: 291-306.
29. Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA, and the Continence Program for Women Research Group. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Neurourol Urodyn 1995;14:131-139.
30. Jorge J, Wexner S. Etiology and management of faecal incontinence. Dis Colon Rectum 1993;36:77-97.
31. Hobart J, Lamping D, Fitzgerald R, Riazi A, Thompson A. The multiple sclerosis impact scale (MSIS-29): a new patient based outcome measure. Brain 2001;124:962-973.
32. Goldberg DP. Manual of the general health questionnaire. Windsor: National Foundation for Educational Research, 1978.
33. Norvedt MW, Riise T, Frugard J, Mohn J, Bakke A, Skar AB, Nyland HI, Glad SB, Myhr KM. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler 2007;13:106-112.
34. Milsom I, Abrams P, Cardoza L, Robers R, Thuroff J, Wein A. How widespread are the symptoms of an overactive bladder and how are they managed? A population based prevalence study. BJU Int 2001;87:760-766.
35. Kesselring J, Beer S. Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 2005;4:643-652.
36. Yang CC, Cardenas DD. Bladder management in women with neurological disabilities. In Womens Issues: Phy Med Rehab Clin N Am 2001;1:91-110.
37. Chia YW, Fowler CJ, KammMA, Henry MM, Lemieux MC, Swash M. Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. J Neurol 1995; 242:105-108.
38. Enck P, Bielefeldt K, Rathmann W, et al. epidemiology of faecal incontinence in selected patient groups. Int J Colorectal Dis 1991;6:143-146.
39. Harvey MA, Kristjansson B, Griffith D, Versi E. The incontinence impact questionnaire and the urogenital distress inventory: a revisit of their validity in women without a urodynamics diagnosis. Am J Obstet Gynecol 2001; 185:25-31.
40. Schwartz CE, Andresen EM, Nosek M. Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil 2007;88:529-536.
41. Sprangers MA, Schwartz CE. Integrating response shift into health related quality of life research: a theoretical model. Soc Sci Med 1999;48:1507-1515.
42. Khan F, Turner Stokes L, Ng L, Kilpatrick T. Multidisciplinary rehabilitation for adults with multiple sclerosis (Review). The Cochrane Database Syst Rev 2007; Art No: CD006036.